FDCDDQ
TARA icon

Federation des caisses Desjardins du Quebec’s Protara Therapeutics TARA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-50
Closed -$1.01K – 2332
2019
Q1 		$1.01K Buy
+50
New +$5.7K ﹤0.01% 1971

Other funds holding TARA

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's TARA Position: Q2 2019 in Review

Federation des caisses Desjardins du Quebec sold out of Protara Therapeutics (TARA) in Q2 2019, closing a stake of 50 shares — an estimated $1.01K sold.

Federation des caisses Desjardins du Quebec first reported a position in TARA in Q1 2019 and held it in 1 quarter. The position peaked at $1.01K in Q1 2019. 15 funds tracked by Wall St. Rank hold TARA as of Q2 2019.

  • Federation des caisses Desjardins du Quebec reported no remaining Protara Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 50 Protara Therapeutics shares in Q2 2019, an estimated $1.01K.
  • Federation des caisses Desjardins du Quebec first reported a position in Protara Therapeutics in Q1 2019 and held it in 1 quarter.
  • Federation des caisses Desjardins du Quebec's Protara Therapeutics position peaked at $1.01K in Q1 2019.
  • 15 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2019.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2019, filed 30 Aug 2024.